|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2007-11-12
|
|
pubmed:abstractText |
Retrospective and anecdotal data suggest that mycophenolate mofetil (MMF) might be effective when given as rescue therapy for membranous nephropathy (MN). Prospective controlled data on MMF and prednisolone as primary therapy are lacking.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1320-5358
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
576-81
|
|
pubmed:meshHeading |
pubmed-meshheading:17995584-Adolescent,
pubmed-meshheading:17995584-Adult,
pubmed-meshheading:17995584-Aged,
pubmed-meshheading:17995584-Female,
pubmed-meshheading:17995584-Glomerulonephritis, Membranous,
pubmed-meshheading:17995584-Humans,
pubmed-meshheading:17995584-Male,
pubmed-meshheading:17995584-Middle Aged,
pubmed-meshheading:17995584-Mycophenolic Acid,
pubmed-meshheading:17995584-Nephrotic Syndrome,
pubmed-meshheading:17995584-Prednisolone,
pubmed-meshheading:17995584-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Prospective controlled study on mycophenolate mofetil and prednisolone in the treatment of membranous nephropathy with nephrotic syndrome.
|
|
pubmed:affiliation |
Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong. dtmchan@hkucc.hku.hk
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
